BRPI0407032A - Vacinas caninas contra bordetella bronchiseptica - Google Patents
Vacinas caninas contra bordetella bronchisepticaInfo
- Publication number
- BRPI0407032A BRPI0407032A BR0407032-1A BRPI0407032A BRPI0407032A BR PI0407032 A BRPI0407032 A BR PI0407032A BR PI0407032 A BRPI0407032 A BR PI0407032A BR PI0407032 A BRPI0407032 A BR PI0407032A
- Authority
- BR
- Brazil
- Prior art keywords
- canine
- caused
- vaccines
- leptospira
- bordetella
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
"VACINAS CANINAS CONTRA BORDETELLA BRONCHISEPTICA". Esta invenção refere-se a vacinas e métodos para a proteção de cães contra a doença causada por Bordebella bronchiseptica. Esta invenção refere-se igualmente a vacinas de combinação e métodos para a proteção de cães contra doença ou distúrbio causado por patógenos caninos, por exemplo, traqueobronquite infecciosa causada por Bordetella bronchi-septica, cinomose causada pelo vírus da cinomose (CD), hepatite canina infecciosa (ICH) causada pelo adenovírus canino do tipo 1 (CAV-1), doença respiratória causada pelo adenovírus canino do tipo 2 (CAV-2), parainfluenza canina causada pelo vírus parainfluenza canina (CPI), enterite causada pelo coronavírus canino (CCV) e parvovírus canino (CPV) , e leptospirose causada pela Leptospira bratislava, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae ou Lepbospira pomona. As vacinas da presente invenção incluem um antígeno p68 de Bordetella bronchiseptica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44341803P | 2003-01-29 | 2003-01-29 | |
PCT/IB2004/000146 WO2004067031A1 (en) | 2003-01-29 | 2004-01-15 | Canine vaccines against bordetella bronchiseptica |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0407032A true BRPI0407032A (pt) | 2006-01-17 |
Family
ID=32825327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0407032-1A BRPI0407032A (pt) | 2003-01-29 | 2004-01-15 | Vacinas caninas contra bordetella bronchiseptica |
Country Status (21)
Country | Link |
---|---|
US (2) | US20040185062A1 (pt) |
EP (1) | EP1592444B1 (pt) |
JP (3) | JP2006515024A (pt) |
KR (1) | KR20050103215A (pt) |
CN (1) | CN1835767A (pt) |
AR (1) | AR042935A1 (pt) |
AT (1) | ATE395077T1 (pt) |
AU (1) | AU2004208556B2 (pt) |
BR (1) | BRPI0407032A (pt) |
CA (1) | CA2513352C (pt) |
DE (1) | DE602004013723D1 (pt) |
ES (1) | ES2303046T3 (pt) |
HR (1) | HRP20050660A2 (pt) |
MX (1) | MXPA05008051A (pt) |
NO (1) | NO20053734L (pt) |
PL (1) | PL378001A1 (pt) |
RU (1) | RU2005124130A (pt) |
TW (1) | TW200505476A (pt) |
UY (1) | UY28171A1 (pt) |
WO (1) | WO2004067031A1 (pt) |
ZA (1) | ZA200506073B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
KR20070008625A (ko) * | 2004-04-05 | 2007-01-17 | 화이자 프로덕츠 인코포레이티드 | 미세유체화된 수중유 유화액 및 백신 조성물 |
EP1871410A2 (en) * | 2005-04-07 | 2008-01-02 | Pharmacia & Upjohn Company LLC | Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
BRPI0603490B1 (pt) * | 2006-07-21 | 2018-04-24 | Universidade Federal De Minas Gerais | Vacina recombinante contra a leishmaniose visceral canina |
KR101238486B1 (ko) * | 2006-09-11 | 2013-03-04 | 화이자 프로덕츠 인크. | 열 처리된 박테린, 및 상기 열 처리된 박테린으로부터 제조된 에멀젼 백신 |
US20100028379A1 (en) * | 2006-12-27 | 2010-02-04 | Pfizer, Inc | Methods of vaccine administration |
JP5470052B2 (ja) * | 2007-02-27 | 2014-04-16 | ゾエティス・ダブリュー・エルエルシー | 動物の感染症を治療または予防するための免疫原組成物 |
ES2728949T3 (es) * | 2008-06-27 | 2019-10-29 | Zoetis Services Llc | Composiciones adyuvantes novedosas |
CA2777692A1 (en) * | 2009-10-14 | 2011-04-21 | Sanjay Kapil | Isolation of a virus related to canine parvovirus-2 from a raccoon |
CN103153337A (zh) * | 2010-09-28 | 2013-06-12 | 共立制药股份有限公司 | 黏膜佐剂组合物 |
CN103261214B (zh) * | 2010-12-22 | 2016-10-26 | 英特维特国际股份有限公司 | 具有活细菌分离物的用于全身施用的疫苗 |
CA2826058C (en) * | 2011-02-04 | 2017-06-06 | Zoetis Llc | Compositions for canine respiratory disease complex |
PL2670432T3 (pl) * | 2011-02-04 | 2021-10-11 | Zoetis Services Llc | Kompozycje immunogenne Bordetella bronchiseptica |
BR112014029725B1 (pt) | 2012-05-31 | 2023-09-26 | Zoetis Services Llc | Usos de coronavírus respiratório canino para proteção contra infecções por b. bronchiseptica |
CZ307883B6 (cs) * | 2013-01-29 | 2019-07-24 | Bioveta, A.S. | Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů |
WO2015042369A2 (en) | 2013-09-19 | 2015-03-26 | Zoetis Llc | Oil-based adjuvants |
PL3244920T3 (pl) | 2015-01-16 | 2023-09-25 | Zoetis Services Llc | Szczepionka przeciw pryszczycy |
BR112017018017A2 (pt) * | 2015-02-26 | 2018-04-10 | Thevax Genetics Vaccine Co Ltd | composição de vacina compreendendo uma proteína imunogênica e adjuvantes de combinação para uso na promoção de respostas de células t específicas de antigenos |
CN106399260B (zh) * | 2015-07-31 | 2021-03-02 | 北京大北农科技集团股份有限公司动物医学研究中心 | 一种犬瘟热、细小病毒病二联活疫苗及其制备方法 |
TW202206098A (zh) * | 2020-08-11 | 2022-02-16 | 美商碩騰服務公司 | 抗冠狀病毒疫苗 |
IT202100014747A1 (it) * | 2021-06-07 | 2022-12-07 | Consiglio Nazionale Ricerche | Derivati sterolici come nuovi ligandi del recettore dectina-1 nel trattamento terapeutico di patologie correlate a tale recettore |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3950512A (en) * | 1972-07-25 | 1976-04-13 | Pitman-Moore, Inc. | Animal vaccines |
GB2048669A (en) * | 1979-05-18 | 1980-12-17 | Moskov Nii Virusnykh Preparato | Canine distemper vaccines |
US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
GB8502399D0 (en) * | 1985-01-31 | 1985-03-06 | Akzo Nv | Canine parvovirus vaccines |
NZ230747A (en) * | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
EP1016416A3 (en) * | 1990-07-06 | 2002-10-23 | Wyeth | Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy |
GB9106568D0 (en) * | 1991-03-27 | 1991-05-15 | Wellcome Found | Recombinant antigen |
ZA927037B (en) * | 1991-09-30 | 1993-03-29 | Akzo Nv | Respiratory disease vaccine for cats. |
JP2521226B2 (ja) * | 1993-01-28 | 1996-08-07 | 株式会社微生物化学研究所 | 犬用多種混合ワクチン |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
AUPO517897A0 (en) * | 1997-02-19 | 1997-04-11 | Csl Limited | Chelating immunostimulating complexes |
GB9718901D0 (en) * | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
-
2004
- 2004-01-15 BR BR0407032-1A patent/BRPI0407032A/pt not_active IP Right Cessation
- 2004-01-15 CN CNA2004800030872A patent/CN1835767A/zh active Pending
- 2004-01-15 AU AU2004208556A patent/AU2004208556B2/en not_active Expired
- 2004-01-15 AT AT04702384T patent/ATE395077T1/de not_active IP Right Cessation
- 2004-01-15 EP EP04702384A patent/EP1592444B1/en not_active Expired - Lifetime
- 2004-01-15 JP JP2005518725A patent/JP2006515024A/ja not_active Withdrawn
- 2004-01-15 ES ES04702384T patent/ES2303046T3/es not_active Expired - Lifetime
- 2004-01-15 MX MXPA05008051A patent/MXPA05008051A/es not_active Application Discontinuation
- 2004-01-15 RU RU2005124130/15A patent/RU2005124130A/ru not_active Application Discontinuation
- 2004-01-15 CA CA2513352A patent/CA2513352C/en not_active Expired - Lifetime
- 2004-01-15 KR KR1020057014122A patent/KR20050103215A/ko not_active Application Discontinuation
- 2004-01-15 WO PCT/IB2004/000146 patent/WO2004067031A1/en active IP Right Grant
- 2004-01-15 PL PL378001A patent/PL378001A1/pl not_active Application Discontinuation
- 2004-01-15 DE DE602004013723T patent/DE602004013723D1/de not_active Expired - Lifetime
- 2004-01-27 AR ARP040100232A patent/AR042935A1/es unknown
- 2004-01-28 UY UY28171A patent/UY28171A1/es not_active Application Discontinuation
- 2004-01-28 TW TW093101852A patent/TW200505476A/zh unknown
- 2004-01-29 US US10/767,809 patent/US20040185062A1/en not_active Abandoned
-
2005
- 2005-07-19 HR HR20050660A patent/HRP20050660A2/hr not_active Application Discontinuation
- 2005-07-28 ZA ZA200506073A patent/ZA200506073B/en unknown
- 2005-08-03 NO NO20053734A patent/NO20053734L/no unknown
-
2006
- 2006-12-20 JP JP2006342944A patent/JP5319882B2/ja not_active Expired - Lifetime
-
2007
- 2007-11-20 US US11/942,843 patent/US7736658B2/en not_active Expired - Lifetime
-
2011
- 2011-02-17 JP JP2011031652A patent/JP2011137017A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1592444A1 (en) | 2005-11-09 |
AU2004208556B2 (en) | 2009-06-04 |
CA2513352C (en) | 2010-10-12 |
EP1592444B1 (en) | 2008-05-14 |
ATE395077T1 (de) | 2008-05-15 |
ES2303046T3 (es) | 2008-08-01 |
CN1835767A (zh) | 2006-09-20 |
JP2011137017A (ja) | 2011-07-14 |
WO2004067031A1 (en) | 2004-08-12 |
RU2005124130A (ru) | 2006-01-20 |
PL378001A1 (pl) | 2006-02-20 |
US20080226670A1 (en) | 2008-09-18 |
ZA200506073B (en) | 2006-05-31 |
JP2006515024A (ja) | 2006-05-18 |
NO20053734D0 (no) | 2005-08-03 |
KR20050103215A (ko) | 2005-10-27 |
NO20053734L (no) | 2005-10-26 |
DE602004013723D1 (de) | 2008-06-26 |
HRP20050660A2 (en) | 2006-02-28 |
JP5319882B2 (ja) | 2013-10-16 |
US20040185062A1 (en) | 2004-09-23 |
UY28171A1 (es) | 2004-08-31 |
TW200505476A (en) | 2005-02-16 |
JP2007161718A (ja) | 2007-06-28 |
US7736658B2 (en) | 2010-06-15 |
AR042935A1 (es) | 2005-07-06 |
AU2004208556A1 (en) | 2004-08-12 |
CA2513352A1 (en) | 2004-08-12 |
MXPA05008051A (es) | 2005-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0407032A (pt) | Vacinas caninas contra bordetella bronchiseptica | |
CY1114897T1 (el) | Πολυδυναμα εμβολια για σκυλους εναντια στην λεπτοσπειρα bratislava και αλλα παθογονα | |
HRP20050192B1 (hr) | Cjepivo za infekcije dišnog i spolnog sustava kod goveda | |
AR064530A1 (es) | Procedimientos para la administracion de vacunas | |
RU2006140984A (ru) | Вакцина против пародонтоза | |
Zhang et al. | Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies | |
WO2004093904A3 (en) | Modified live vaccines comprising bhv-1(ibr) and/or bvdv pregnant and nursing cattles | |
BRPI0407436A (pt) | Composições adesivas para dentaduras, bem como método para a obtenção de efeito antiplaca | |
PT784486E (pt) | Inerleucina-12 como um adjuvante para vacinas contra paramyxoviridae | |
WO2008106393A3 (en) | Immunogenic compositions and methods for treating and preventing animal infections | |
RU2006133328A (ru) | Способ вакцинации против инфекции семенников bvdv | |
DE60045685D1 (de) | Dns-impfstoffe für hunde | |
CO5690616A2 (es) | Vacunas para enfermedades reproductoras del ganado | |
TH94300A (th) | องค์ประกอบก่อภูมิคุ้มกัน pcv2 ชนิดมัลติเวเลนต์ และวิธีของการผลิตองค์ประกอบเหล่านี้ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A, 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |